Brief: Themis Medicare Says Central Licensing Authority Says No Objection To Manufacturing And Marketing Of Diclofenac Injection

Themis Medicare

17/02/2023 07:12

Feb 17 (Reuters) - Themis Medicare Ltd  THEM.NS :
    * CENTRAL LICENSING AUTHORITY SAYS NO OBJECTION TO
MANUFACTURING
AND MARKETING OF DICLOFENAC INJECTION
    * CO TO EXAMINE VARIOUS OPTIONS TO COMMERCIALISE DICLOFENAC
INJECTION
    * CO TO DEAL WITH PENDING LITIGATION IN CONSULTATION WITH
ITS
LEGAL ADVISORS

Source text for Eikon:  ID:nNSEc3xVJm 
Further company coverage:  THEM.NS 
 ((Reuters.Briefs@thomsonreuters.com;;))